Health
Mefloquine shows potential as anti-SARS-CoV-2 drug – News-Medical.Net
A team of scientists from Japan has identified the approved anti-material drug, mefloquine, as a potential candidate to treat severe acute respiratory syndrome…
A team of scientists from Japan has identified the approved anti-material drug, mefloquine, as a potential candidate to treat severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Specifically, mefloquine has been shown to prevent the entry of SARS-CoV-2 into host cells and reduce the viral loadin vitro. The study is currently available on the bioRxiv* preprint server.
The recent pandemic of coronavirus disease 2019 (COVID-19) has put a substantial amount of burden on healthcare…
-
Noosa News23 hours agoReubhan Ralph identified as man behind terrifying childcare centre incident in Peregian Springs on the Sunshine Coast
-
General21 hours agoPolice say new leads being pursued after baby’s body found in Alexander Heights stormwater drain
-
Noosa News24 hours agoSchoolgirls hit by fishtailing car in terrifying crash in Bellbird Park, Ipswich
-
Noosa News21 hours agoPolice charge second man over alleged assault in Gold Coast car seller on Facebook’s Marketplace